Clinical Trial Update: Dexmedetomidine Pharmacokinetics in the Obese [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study in obese participants to evaluate how obesity affects dexmedetomidine exposure. The study status indicates completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Pontificia Universidad Catolica de Chile | Conditions: Obesity | Phase 4 | Status: COMPLETED